The FDA recently approved a new rapid-acting mealtime insulin called Lyumjev, which is absorbed into the body more quickly than Humalog and is designed to target post-meal spikes and reduce A1c.
read more →
Dr. Edelman speaks with diabetes attorney Kriss Halpern, who discusses employee rights for people with diabetes as well as returning to work during COVID-19.
read more →
LADA (Latent Autoimmune Diabetes in Adults) is the most missed diagnosis in diabetes. It’s often initially diagnosed as type 2 because the loss of pancreatic beta cells is much slower than the more “traditional” form of type 1.
read more →
Priced at a third of the cost of other CGMs, this latest technology from Abbott is the first and only iCGM that sustains performance for up to 14 days and provides trends, insights and customizable high and low alerts.
read more →
We’ve ditched the bun and added greens and guac for two delectable ways to showcase a new addition to the burger family.
read more →
